Problems and Approaches for Blood Transfusion in the Developing Countries

Hematology/Oncology Clinics of North America

Volumn 30, Issue 2, 2016, Pages 477-495

  Roberts, David J ^a   Field, Stephen ^b   Delaney, Meghan ^c   Bates, Imelda ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Welsh Blood Service   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Blood donor; Blood transfusion; Transfusion transmitted infection; Use of blood

Indexed keywords

AFRICA; AFRICA SOUTH OF THE SAHARA; BACTERIUM CONTAMINATION; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; CHRONIC HEPATITIS B; CLINICAL PRACTICE; DEVELOPING COUNTRY; EBOLA HEMORRHAGIC FEVER; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FINANCIAL MANAGEMENT; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; MALARIA; NATIONAL HEALTH SERVICE; NIGERIA; NONHUMAN; PANDEMIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SYPHILIS; WEST AFRICA; WORLD HEALTH ORGANIZATION; ADVERSE EFFECTS; ECONOMICS; PROCEDURES; STANDARDS; TOTAL QUALITY MANAGEMENT;

BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; DEVELOPING COUNTRIES; HUMANS; QUALITY IMPROVEMENT;

EID: 84963664657     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2015.11.011     Document Type: Review

References (107)

1. Lackritz E.M., Campbell C.C., Ruebush T.K., et al. Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 1992, 340(8818):524-528.
2. Bates I., Chapotera G.K., McKew S., et al. Maternal mortality in sub-Saharan Africa: the contribution of ineffective blood transfusion services. BJOG 2008, 115(11):1331-1339.
3. World Health Organization. Developing a national blood system. 2015. Available at: . Accessed November 1, 2015. http://www.who.int/bloodsafety/clinical_use/en/.
4. Tapko J.B., Sam O. Diarra-Nama A. Report on the status of blood safety in the WHO African region for 2004 2007, World Health Organization, Geneva, Switzerland.
5. Cunha L., Plouzeau C., Ingrand P., et al. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol 2007, 79(12):1832-1840.
6. Tagny C.T., Diarra A., Yahaya R., et al. Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion 2009, 49(8):1592-1599.
7. Tagny C.T., Owusu-Ofori S., Mbanya D., et al. The blood donor in sub-Saharan Africa: a review. Transfus Med 2010, 20(1):1-10.
8. Keshvari M., Hajibeigi B., Azarkeivan A., et al. Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients. Transfus Med 2014, 24(4):227-232.
9. Kiggundu V.L., O'Meara W.P., Musoke R., et al. High prevalence of malaria parasitemia and anemia among hospitalized children in Rakai, Uganda. PLoS One 2013, 8(12):e82455.
10. Bugge H.F., Karlsen N.C., Oydna E., et al. A study of blood transfusion services at a district hospital in Malawi. Vox Sang 2013, 104(1):37-45.
11. Comfort A.B., van Dijk J.H., Mharakurwa S., et al. Association between malaria control and paediatric blood transfusions in rural Zambia: an interrupted time-series analysis. Malar J 2014, 13:383.
12. Austin N., Adikaibe E., Ethelbert O., et al. Prevalence and severity of malaria parasitemia among children requiring emergency blood transfusion in a tertiary hospital in Imo State, Nigeria. Ann Med Health Sci Res 2014, 4(4):619-623.
13. Mungai M., Tegtmeier G., Chamberland M., et al. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001, 344(26):1973-1978.
14. O'Brien S.F., Delage G., Seed C.R., et al. The epidemiology of imported malaria and transfusion policy in 5 nonendemic countries. Transfus Med Rev 2015, 29(3):162-171.
15. Owusu-Ofori A.K., Parry C., Bates I. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis 2010, 51(10):1192-1198.
16. Owusu-Ofori A.K., Betson M., Parry C.M., et al. Transfusion-transmitted malaria in Ghana. Clin Infect Dis 2013, 56(12):1735-1741.
17. Rajab J.A., Waithaka P.M., Orinda D.A., et al. Analysis of cost and effectiveness of pre-transfusion screening of donor blood and anti-malarial prophylaxis for recipients. East Afr Med J 2005, 82(11):565-571.
18. Owusu-Ofori A.K., Bates I. Impact of inconsistent policies for transfusion-transmitted malaria on clinical practice in Ghana. PLoS One 2012, 7(3):e34201.
19. Adjei A.A., Kuma G.K., Tettey Y., et al. Bacterial contamination of blood and blood components in three major blood transfusion centers, Accra, Ghana. Jpn J Infect Dis 2009, 62(4):265-269.
20. Hassall O., Maitland K., Pole L., et al. Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospital. Transfusion 2009, 49(12):2594-2598.
21. Keshvari M., Alavian S.M., Aghaee B., et al. Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from hepatitis clinic of Iranian Blood Transfusion Organization. Transfus Med 2014, 24(6):411-417.
22. Kapoor D., Saxena R., Sood B., et al. Blood transfusion practices in India: results of a national survey. Indian J Gastroenterol 2000, 19:64-67.
23. Chaudhuri V., Nanu A., Panda S.K., et al. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion 2003, 43(10):1442-1448.
24. Basavaraju S.V., Mwangi J., Nyamongo J., et al. Reduced risk of transfusion-transmitted HIV in Kenya through centrally coordinated blood centres, stringent donor selection and effective p24 antigen-HIV antibody screening. Vox Sang 2010, 99(3):212-219.
25. Adouani B., Alami R., Laouina A., et al. Hepatitis B in Moroccan blood donors: a decade trend of the HBsAg prevalence in a resources limited country. Transfus Med 2013, 23(6):432-437.
26. Alvarado-Mora M.V., Pinho J.R. Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther 2013, 18(3 Pt B):429-433.
27. Apata I.W., Averhoff F., Pitman J., et al. Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection-sub-Saharan Africa, 2000-2011. MMWR Morb Mortal Wkly Rep 2014, 63(29):613-619.
28. WHO. Global database on blood safety. Available at: . Accessed November 1, 2015. http://www.who.int/bloodsafety/global_database/en/.
29. Mansour A.K., Aly R.M., Abdelrazek S.Y., et al. Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients. Hematol Oncol Stem Cell Ther 2012, 5(1):54-59.
30. Seck S.M., Dahaba M., Gueye S., et al. Trends in hepatitis C infection among hemodialysis patients in Senegal: results of a decade of prevention. Saudi J Kidney Dis Transpl 2014, 25(6):1341-1345.
31. Mapako T., Mvere D.A., Chitiyo M.E., et al. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety. Transfusion 2013, 53(10 Pt 2):2413-2421.
32. Rerambiah L.K., Rerambiah L.E., Djoba Siawaya J.F., et al. The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. Blood Transfus 2014, 12(3):330-333.
33. Dodd R.Y., Foster G.A., Stramer S.L. Keeping blood transfusion safe from West Nile virus: American red cross experience, 2003 to 2012. Transfus Med Rev 2015, 29(3):153-161.
34. Arellanos-Soto D., B-d l Cruz V., Mendoza-Tavera N., et al. Constant risk of dengue virus infection by blood transfusion in an endemic area in Mexico. Transfus Med 2015, 25(2):122-124.
35. Lanteri M.C., Busch M.P. Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen?. Transfusion 2012, 52(8):1634-1639.
36. Gan V.C., Leo Y.S. Current epidemiology and clinical practice in arboviral infections - implications on blood supply in South-East Asia. ISBT Sci Ser 2014, 9(1):262-267.
37. Brouard C., Bernillon P., Quatresous I., et al. Estimated risk of chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion 2008, 48(7):1333-1341.
38. Bates I., Manyasi G., Medina Lara A. Reducing replacement donors in Sub-Saharan Africa: challenges and affordability. Transfus Med 2007, 17(6):434-442.
39. Starr D. Blood: an epic history of medicine and commerce 2002, Harper Collins, New York.
40. Allain J.P. Moving on from voluntary non-remunerated donors: who is the best blood donor?. Br J Haematol 2011, 154(6):763-769.
41. Ferreira S.C., de Almeida-Neto C., Nishiya A.S., et al. Demographic, risk factors and motivations among blood donors with reactive serologic tests for syphilis in São Paulo, Brazil. Transfus Med 2014, 24(3):169-175.
42. Akech S.O., Hassall O., Pamba A., et al. Survival and haematological recovery of children with severe malaria transfused in accordance to WHO guidelines in Kilifi, Kenya. Malar J 2008, 7:256.
43. Kiguli S., Maitland K., George E.C., et al. Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness. BMC Med 2015, 13:21.
44. Ray S., Madzimbamuto F.D., Ramagola-Masire D., et al. Review of causes of maternal deaths in Botswana in 2010. S Afr Med J 2013, 103(8):537-542.
45. Bloch E.M., Crookes R.L., Hull J., et al. The impact of human immunodeficiency virus infection on obstetric hemorrhage and blood transfusion in South Africa. Transfusion 2015, 55(7):1675-1684.
46. Compaore G.D., Sombié I., Ganaba R., et al. Readiness of district and regional hospitals in Burkina Faso to provide caesarean section and blood transfusion services: a cross-sectional study. BMC Pregnancy Childbirth 2014, 14:158.
47. Lagunju I.A., Brown B.J., Sodeinde O.O. Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal. Pediatr Blood Cancer 2013, 60(12):1940-1945.
48. Lagunju I.A., Brown B.J., Sodeinde O.O. Stroke recurrence in Nigerian children with sickle cell disease treated with hydroxyurea. Niger Postgrad Med J 2013, 20(3):181-187.
49. Galadanci N.A., Abdullahi S.U., Tabari M.A., et al. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial. Pediatr Blood Cancer 2015, 62(3):395-401.
50. Lagunju I., Brown B.J., Sodeinde O. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort. Pediatr Blood Cancer 2015, 62(9):1587-1591.
51. El-Beshlawy A., El-Ghamrawy M., EL-Ela M.A., et al. Response to hydroxycarbamide in pediatric beta-thalassemia intermedia: 8 years' follow-up in Egypt. Ann Hematol 2014, 93(12):2045-2050.
52. Javadzadeh Shahshahani H., Hatami H., Meraat N., et al. Epidemiology of blood component recipients in hospitals of Yazd, Iran. Transfus Med 2015, 25(1):2-7.
53. Butler E.K., Hume H., Birungi I., et al. Blood utilization at a national referral hospital in sub-Saharan Africa. Transfusion 2015, 55(5):1058-1066.
54. English M., Ahmed M., Ngando C., et al. Blood transfusion for severe anaemia in children in a Kenyan hospital. Lancet 2002, 359(9305):494-495.
55. Organization, W.H. Universal access to safe blood transfusion. 2015. Available at: . Accessed November 1, 2015. http://www.who.int/bloodsafety/universalbts/en/.
56. Pourfathollah A.A., Hosseini Divkolaye N.S., Seighali F. Four decades of National Blood Service in Iran: outreach, prospect and challenges. Transfus Med 2015, 25(3):138-143.
57. Zaheer H.A., Waheed U. Legislative reforms of the blood transfusion system in Pakistan. Transfus Med 2014, 24(2):117-119.
58. Ala F., Allain J.P., Bates I., et al. External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med 2012, 9(9):e1001309.
59. Africa, S.B.f. Safe Blood for Africa Foundation 2015. Available at: . Accessed November 11, 2015. http://www.safebloodforafrica.org/index.php?option=com_content&view=article&id=344&Itemid=516.
60. Allain J.P., Sarkodie F., Boateng P., et al. A pool of repeat blood donors can be generated with little expense to the blood center in sub-Saharan Africa. Transfusion 2008, 48(4):735-741.
61. Muthivhi T.N., Olmsted M.G., Park H., et al. Motivators and deterrents to blood donation among Black South Africans: a qualitative analysis of focus group data. Transfus Med 2015, 25(4):249-258.
62. CRASH-2 Trial Collaborators, Shakur H., Roberts I., et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010, 376(9734):23-32.
63. Hassall O., Bedu-Addo G., Adarkwa M., et al. Umbilical-cord blood for transfusion in children with severe anaemia in under-resourced countries. Lancet 2003, 361(9358):678-679.
64. Hassall O.W., Thitiri J., Fegan G., et al. The microbiologic safety of umbilical cord blood transfusion for children with severe anemia in Mombasa, Kenya. Transfusion 2012, 52(7):1542-1551.
65. Laperche S., Francophone African Group for Research in Blood Transfusion Multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion 2013, 53(4):816-826.
66. Pruett C.R., Vermeulen M., Zacharias P., et al. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review. Transfus Med Rev 2015, 29(1):35-44.
67. Orkuma J.A., Egesie J.O., Banwat E.B., et al. HIV screening in blood donors: rapid diagnostic test versus enhanced ELISA. Niger J Med 2014, 23(3):192-200.
68. Bloch E.M., Shah A., Kaidarova Z., et al. A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries. Vox Sang 2014, 107(4):333-342.
69. Vermeulen M., Lelie N., Sykes W., et al. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009, 49(6):1115-1125.
70. Bruhn R., Lelie N., Custer B., et al. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios. Transfusion 2013, 53(10 Pt 2):2399-2412.
71. Andrea P., Kupek E., Genovez G., et al. NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results. Transfus Med 2015, 25(2):125-127.
72. Vermeulen M., Coleman C., Mitchel J., et al. Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections. Transfusion 2013, 53(10 Pt 2):2459-2466.
73. Cable R., Lelie N., Bird A. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review. Vox Sang 2013, 104(2):93-99.
74. Shyamala V. Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India. Transfus Med 2014, 24(2):79-88.
75. Ritchie A.V., Ushiro-Lumb I., Edemaga D., et al. SAMBA HIV semiquantitative test, a new point-of-care viral-load-monitoring assay for resource-limited settings. J Clin Microbiol 2014, 52(9):3377-3383.
76. Zeng P., Liu J., Wang J., et al. Parallel enzyme-linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis. Transfus Med 2015, 25(4):259-264.
77. Hensher M., Jefferys E. Financing blood transfusion services in sub-Saharan Africa: a role for user fees?. Health Policy Plan 2000, 15:287-295.
78. Sonnekus P.H., Louw V.J., Ackermann A.M., et al. An audit of the use of platelet transfusions at Universitas Academic Hospital, Bloemfontein, South Africa. Transfus Apher Sci 2014, 51(3):44-52.
79. Harrison M.C., Pillay S., Joolay Y., et al. Resource implications of adopting a restrictive neonatal blood transfusion policy. S Afr Med J 2013, 103(12):916-917.
80. Adeleye A.O. Targeting a zero blood transfusion rate in the repair of craniospinal dysraphism: outcome of a surgical technique for developing countries. Neurol Res 2015, 37(2):125-130.
81. Solomon L., von Rahden R.P., Allorto N.L. Intra-operative cell salvage in South Africa: feasible, beneficial and economical. S Afr Med J 2013, 103(10):754-757.
82. Barrett C.L., Louw V.J., Webb M.J. Exchange transfusion as a life-saving intervention in three patients with different haematological malignancies with severe hyperleukocytosis where leukapheresis was not available. Transfus Apher Sci 2013, 49(3):397-402.
83. Murphy M.F. The Choosing Wisely campaign to reduce harmful medical overuse: its close association with Patient Blood Management initiatives. Transfus Med 2015, 25(5):287-292.
84. Opare-Sem O., Bedu-Addo G., Karikari P., et al. Fourteen-year experience of a tertiary hospital transfusion committee in West Africa. Transfusion 2014, 54(11):2852-2862.
85. Ibrahim N.U., Garba N., Tilde I.M. Acute blood transfusion reactions in pregnancy, an observational study from North Eastern Nigeria. J Blood Disord Transfus 2013, 4:145. 10.4172/2155-9864.1000145.
86. Meza B.P., Lohrke B., Wilkinson R., et al. Estimation of the prevalence and rate of acute transfusion reactions occurring in Windhoek, Namibia. Blood Transfus 2014, 12(3):352-361.
87. Dahourou H., Tapko J.B., Nébié Y., et al. Implementation of hemovigilance in Sub-Saharan Africa. Transfus Clin Biol 2012, 19(1):39-45. [in French].
88. Basavaraju S.V., Lohrke B., Pitman J.P., et al. Knowledge and barriers related to reporting of acute transfusion reactions among healthcare workers in Namibia. Transfus Med 2013, 23(5):367-369.
89. Diarra A.B., Guindo A., Kouriba B., et al. Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients. Transfus Clin Biol 2013, 20(5-6):476-481. [in French].
90. Hussein E., Desooky N., Rihan A., et al. Predictors of red cell alloimmunization in multitransfused Egyptian patients with beta-thalassemia. Arch Pathol Lab Med 2014, 138(5):684-688.
91. Zaidi U., Borhany M., Ansari S., et al. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Transfus Med 2015, 25(2):106-110.
92. Granier T., Beley S., Chiaroni J., et al. A comprehensive survey of both RHD and RHCE allele frequencies in sub-Saharan Africa. Transfusion 2013, 53(11 Suppl 2):3009-3017.
93. Kappler-Gratias S., Auxerre C., Dubeaux I., et al. Systematic RH genotyping and variant identification in French donors of African origin. Blood Transfus 2014, 12(Suppl 1):s264-s272.
94. Wang M., Wang B.L., Xu W., et al. Anti-D alloimmunisation in pregnant women with DEL phenotype in China. Transfus Med 2015, 25(3):163-169.
95. Dzik W.S., Kyeyune D., Otekat G., et al. Transfusion Medicine in Sub-Saharan Africa: conference summary. Transfus Med Rev 2015, 29(3):195-204.
96. Waiswa M.K., Moses A., Seremba E., et al. Acute transfusion reactions at a national referral hospital in Uganda: a prospective study. Transfusion 2014, 54(11):2804-2810.
97. Gulland A. Clinical trials of Ebola therapies to begin in December. BMJ 2014, 349:g6827.
98. Gutfraind A., Meyers L.A. Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia. J Infect Dis 2015, 211(8):1262-1267.
99. Burnouf T., Emmanuel J., Mbanya D., et al. Ebola: a call for blood transfusion strategy in sub-Saharan Africa. Lancet 2014, 384(9951):1347-1348.
100. Eichbaum Q., Shan H., Goncalez T.T., et al. Global health and transfusion medicine: education and training in developing countries. Transfusion 2014, 54(7):1893-1898.
101. Damulak O.D., Jatau E., Akinga E., et al. The prevalence of syphilis among blood donors in a centralized Nigerian Blood Transfusion Service Centre. Niger J Med 2013, 22(2):113-116.
102. Louw V.J. Determining the outcomes for clinicians completing a postgraduate diploma in transfusion medicine. Transfus Apher Sci 2014, 51(3):38-43.
103. Louw V.J. Transfusion education and practice in South Africa. Transfus Apher Sci 2014, 51(3):6-7.
104. Olaleye D.O., Odaibo G.N., Carney P., et al. Enhancement of health research capacity in Nigeria through north-south and in-country partnerships. Acad Med 2014, 89(8 Suppl):S93-S97.
105. MUHAS. Muhimbili Wellcome Programme. Training and Capacity Building - MMed in Haematology and Blood Transfusion. Available at: . Accessed November 11, 2015. http://www.muhimbili-wellcome.org/training.
106. Tagny C.T., Murphy E.L., Lefrère J.J., et al. The Francophone Africa Blood Transfusion Research Network: a five-year report. Transfus Clin Biol 2014, 21(1):37-42. [in French].
107. Bates I, Hassall O. Workshop on blood transfusion research in sub-Saharan Africa. 2015. Available at: . Accessed November 1, 2015. http://www.t-rec.eu/highlights/documents/Workshoponbloodtransfusionresearchinsub-SaharanAfricaexternal.pdf.